Kymera Therapeutics Inc Asset Turnover Ratio (KYMR), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kymera Therapeutics Inc   (NASDAQ: KYMR)
 

Kymera Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kymera Therapeutics Inc asset turnover ratio, the ability of Kymera Therapeutics Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.04 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as KYMR's position remain challenging.

Within sector 35 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2409 to 2595.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYMR Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 81.75 % 88.03 % 12.23 % 46.02 % 12.68 %
Y / Y Revenue Change 55.5 % -61.17 % -26.12 % -55.26 % 114.83 %
Asset Turnover Ratio (TTM) 0.04 0.03 0.04 0.05 0.07
KYMR's Total Ranking # 2595 # 2409 # 2210 # 2983 # 2586
Seq. Asset Change -4.23 % 58.14 % -2.57 % 23.17 % -0.92 %
Seq. Revenue Change 1096.97 % 3.87 % -75.91 % -48.07 % 198.89 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 36
Healthcare Sector # 361
Overall Market # 2595

Asset Turnover Ratio Statistics
High Average Low
2550.08 426.54 3.92
(Mar 31 2022)   (Dec 31 2025)




KYMR Company Profile • Back to KYMR Efficiency Comparisons • Compare KYMR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Ocugen Inc   0.08 $ 4.465  Millions$ 52.903  Millions
Lenz Therapeutics Inc   0.08 $ 20.989  Millions$ 251.612  Millions
Stoke Therapeutics Inc   0.08 $ 32.080  Millions$ 401.621  Millions
Keros Therapeutics Inc   0.08 $ 42.450  Millions$ 537.566  Millions
Cytokinetics Incorporated  0.08 $ 105.815  Millions$ 1,340.052  Millions
Intellia Therapeutics Inc   0.08 $ 66.092  Millions$ 856.269  Millions
Longeveron Inc   0.08 $ 1.216  Millions$ 15.944  Millions
Tonix Pharmaceuticals Holding Corp   0.07 $ 17.556  Millions$ 243.721  Millions
Surrozen Inc   0.07 $ 7.494  Millions$ 104.044  Millions
Armata Pharmaceuticals Inc   0.07 $ 5.693  Millions$ 79.247  Millions
Biorestorative Therapies Inc   0.06 $ 0.363  Millions$ 5.720  Millions
Vir Biotechnology Inc   0.06 $ 65.495  Millions$ 1,060.098  Millions
Agape Atp Corporation  0.06 $ 1.509  Millions$ 24.653  Millions
Caribou Biosciences Inc   0.06 $ 11.203  Millions$ 185.063  Millions
Alector Inc   0.06 $ 18.417  Millions$ 306.215  Millions
Prophase Labs Inc   0.06 $ 3.386  Millions$ 56.586  Millions
Abcellera Biologics Inc   0.06 $ 79.208  Millions$ 1,355.529  Millions
Grail Inc   0.06 $ 156.120  Millions$ 2,757.268  Millions
Nexalin Technology Inc   0.06 $ 0.276  Millions$ 5.005  Millions
Kyntra Bio Inc   0.05 $ 7.439  Millions$ 136.073  Millions
Agios Pharmaceuticals Inc   0.05 $ 66.048  Millions$ 1,334.789  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.949  Millions$ 40.159  Millions
Recursion Pharmaceuticals Inc   0.05 $ 66.408  Millions$ 1,378.883  Millions
Seer Inc   0.05 $ 14.386  Millions$ 299.828  Millions
Aligos Therapeutics Inc   0.05 $ 4.705  Millions$ 99.390  Millions
Astrotech Corp  0.05 $ 1.008  Millions$ 21.525  Millions
Aclaris Therapeutics Inc   0.05 $ 8.367  Millions$ 180.965  Millions
Camp4 Therapeutics Corporation  0.04 $ 3.934  Millions$ 90.234  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.014  Millions$ 207.366  Millions
Catheter Precision Inc   0.04 $ 1.108  Millions$ 25.495  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.